down arrow

Bluejay Diagnostics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0956333019
USD
1.22
0.03 (2.52%)

Dec 05

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.201.24

52 Week

1.1310.20
Valuation
Technical
Day's Volume

CASH

9.01 k

Shareholding (Mar 2025)

FII

0.01%

Held by 3 FIIs

DII

99.23%

Held by 1 DIIs

Promoter

0.00%

How big is Bluejay Diagnostics, Inc.?

22-Jun-2025

As of Jun 18, Bluejay Diagnostics, Inc. has a market capitalization of 2.44 million, with net sales of 0.00 million and a net profit of -7.25 million over the last four quarters. The company reported shareholder's funds of 5.73 million and total assets of 6.66 million as of Dec 24.

Market Cap: As of Jun 18, Bluejay Diagnostics, Inc. has a market capitalization of 2.44 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Bluejay Diagnostics, Inc. reported net sales of 0.00 million and a net profit of -7.25 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 5.73 million and total assets of 6.66 million.

Read More

What does Bluejay Diagnostics, Inc. do?

22-Jun-2025

Bluejay Diagnostics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $2.44 million. Key financial metrics include a negative P/E ratio, no dividend yield, and a return on equity of -187.61%.

Overview:<BR>Bluejay Diagnostics, Inc. operates in the Pharmaceuticals & Biotechnology industry and falls within the micro-cap market segment.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 2.44 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.78 <BR>Return on Equity: -187.61% <BR>Price to Book: 0.63 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Bluejay Diagnostics, Inc. technically bullish or bearish?

20-Sep-2025

As of August 12, 2025, Bluejay Diagnostics, Inc. shows a mildly bearish trend with mixed momentum indicators, having underperformed the S&P 500 significantly over the past year.

As of 12 August 2025, the technical trend for Bluejay Diagnostics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are mildly bearish, and the Bollinger Bands show a bearish stance on the weekly and mildly bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly, suggesting mixed signals across time frames. <BR><BR>In terms of performance, the stock has significantly underperformed the S&P 500 over the year, with a return of -79.64% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, influenced by the bearish moving averages and mixed momentum indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.82

stock-summary
Return on Equity

-127.31%

stock-summary
Price to Book

0.40

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.86%
0%
-15.86%
6 Months
-19.74%
0%
-19.74%
1 Year
-80.32%
0%
-80.32%
2 Years
-99.91%
0%
-99.91%
3 Years
99.9%
0%
99.9%
4 Years
-99.99%
0%
-99.99%
5 Years
0%
0%
0.0%

Bluejay Diagnostics, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Bluejay Diagnostics, Inc. technically bullish or bearish?

As of 12 August 2025, the technical trend for Bluejay Diagnostics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are mildly bearish, and the Bollinger Bands show a bearish stance on the weekly and mildly bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly, suggesting mixed signals across time frames. In terms of performance, the stock has significantly underperformed the S&P 500 over the year, with a return of -79.64% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, influenced by the bearish moving averages and mixed momentum indicators....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-229.36%
EBIT to Interest (avg)
-7.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.78
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.32%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.87
EV to EBIT
-0.05
EV to EBITDA
-0.05
EV to Capital Employed
0.35
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-663.04%
ROE (Latest)
-187.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (0.76%)

Foreign Institutions

Held by 3 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -5.26% vs -35.71% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.90",
          "val2": "-1.80",
          "chgp": "-5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.00",
          "val2": "-1.90",
          "chgp": "-5.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 23.00% vs -7.53% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.00",
          "val2": "-9.50",
          "chgp": "26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.70",
          "val2": "-10.00",
          "chgp": "23.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.90
-1.80
-5.56%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.00
-1.90
-5.26%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -5.26% vs -35.71% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-7.00
-9.50
26.32%
Interest
0.80
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-7.70
-10.00
23.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 23.00% vs -7.53% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Bluejay Diagnostics, Inc. stock-summary
stock-summary
Bluejay Diagnostics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."